Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer (Q37803144)

23 August 2017

Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer (English)

1 reference

23 August 2017

1 reference

1 reference

Rupal Ramakrishnan

1

1 reference

PubMed ID

20976448

23 August 2017

Dmitry I Gabrilovich

series ordinal

2

1 reference

23 August 2017

26 October 2010

1 reference

Cancer Immunology, Immunotherapy

23 August 2017

1 reference

23 August 2017

60

1 reference

23 August 2017

3

1 reference

23 August 2017

419-423

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-010-0930-1

23 August 2017

0 references

cites work

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Cancer vaccines: moving beyond current paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Immunogenic and tolerogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Cell-surface expression of Hsp70 on hematopoietic cancer cells after inhibition of HDAC activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Mechanism and therapeutic reversal of immune suppression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Cisplatin: synthesis, antitumour activity and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

The soluble type 2 insulin-like growth factor (IGF-II) receptor reduces organ size by IGF-II-mediated and IGF-II-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Demonstration of tumor suppression by mannose 6-phosphate/insulin-like growth factor 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Granzyme-mediated cytotoxicity does not involve the mannose 6-phosphate receptors on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

The mannose 6-phosphate receptor and the biogenesis of lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

New Paradigm for Lymphocyte Granule-mediated Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0930-1

10.1007/S00262-010-0930-1

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20976448